Akorn (AKRX) Set to Announce Quarterly Earnings on Tuesday

Akorn (NASDAQ:AKRX) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Akorn to post earnings of ($0.11) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Akorn (NASDAQ:AKRX) last announced its quarterly earnings data on Thursday, February 28th. The company reported ($0.32) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.31). The firm had revenue of $153.39 million for the quarter, compared to analysts’ expectations of $164.75 million. Akorn had a negative return on equity of 13.34% and a negative net margin of 57.91%. The firm’s quarterly revenue was down 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 EPS. On average, analysts expect Akorn to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Akorn stock opened at $2.85 on Friday. The firm has a market cap of $357.90 million, a price-to-earnings ratio of -7.92 and a beta of 2.61. The company has a quick ratio of 2.40, a current ratio of 3.42 and a debt-to-equity ratio of 1.85. Akorn has a one year low of $2.64 and a one year high of $19.65.

A number of equities analysts have recently issued reports on AKRX shares. BidaskClub downgraded shares of Akorn from a “buy” rating to a “hold” rating in a report on Wednesday, April 10th. SunTrust Banks started coverage on shares of Akorn in a report on Tuesday, March 19th. They issued a “hold” rating and a $4.00 price target for the company. Zacks Investment Research downgraded shares of Akorn from a “hold” rating to a “sell” rating in a report on Thursday, April 25th. Royal Bank of Canada set a $4.00 price target on shares of Akorn and gave the company a “hold” rating in a report on Friday, March 1st. Finally, Piper Jaffray Companies set a $8.00 price target on shares of Akorn and gave the company a “buy” rating in a report on Friday, March 1st. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $8.17.

TRADEMARK VIOLATION NOTICE: This news story was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/05/akorn-akrx-set-to-announce-quarterly-earnings-on-tuesday.html.

About Akorn

Akorn, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health.

See Also: What is an overbought condition?

Earnings History for Akorn (NASDAQ:AKRX)

Receive News & Ratings for Akorn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akorn and related companies with MarketBeat.com's FREE daily email newsletter.